Literature DB >> 15314247

Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment.

Tzvi Dwolatzky1, Victor Whitehead, Glen M Doniger, Ely S Simon, Avraham Schweiger, Dena Jaffe, Howard Chertkow.   

Abstract

The NeuroTrax Mindstreams computerized cognitive assessment system was designed for widespread clinical and research use in detecting mild cognitive impairment (MCI). However, the capability of Mindstreams tests to discriminate the elderly with MCI from those who are cognitively healthy has yet to be evaluated. Moreover, the comparability between these tests and traditional neuropsychological tests in detecting MCI has not been examined. A two-center study was designed to assess the discriminant validity of tests in the Mindstreams Mild Impairment Battery. Participants were 30 individuals diagnosed with MCI, 29 with mild Alzheimer's disease (AD), and 39 healthy elderly. Testing was with the Mindstreams battery and traditional neuropsychological tests. Receiver operating characteristic (ROC) analysis was used to examine the ability of Mindstreams and traditional measures to discriminate those with MCI from cognitively healthy elderly. Between-group comparisons were made (Mann-Whitney U test) between MCI and healthy elderly and between MCI and mild AD groups. Mindstreams outcome parameters across multiple cognitive domains significantly discriminated between MCI and healthy elders with considerable effect sizes (p < 0.05). Measures of memory, executive function, visual spatial skills, and verbal fluency discriminated best, and discriminability was at least comparable to that of traditional neuropsychological tests in these domains. Mindstreams tests are effective in detecting MCI, providing a comprehensive profile of cognitive function. Further, the enhanced precision and ease of use of these computerized tests make the NeuroTrax system a valuable clinical tool in the identification of elders at high risk for dementia. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15314247     DOI: 10.1385/jmn:24:1:033

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

Review 2.  MicroCog: assessment of cognitive functioning.

Authors:  R W Elwood
Journal:  Neuropsychol Rev       Date:  2001-06       Impact factor: 7.444

Review 3.  Mild cognitive impairment in older people.

Authors:  Alistair Burns; Michael Zaudig
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

4.  Visual memory predicts Alzheimer's disease more than a decade before diagnosis.

Authors:  C H Kawas; M M Corrada; R Brookmeyer; A Morrison; S M Resnick; A B Zonderman; D Arenberg
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

5.  Word-reading thresholds in Alzheimer disease and mild memory loss: a pilot study.

Authors:  Fadi Massoud; Howard Chertkow; Victor Whitehead; Olga Overbury; Howard Bergman
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Jan-Mar       Impact factor: 2.703

6.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.

Authors:  R C Mohs; W G Rosen; K L Davis
Journal:  Psychopharmacol Bull       Date:  1983

7.  Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

Authors:  A Bozoki; B Giordani; J L Heidebrink; S Berent; N L Foster
Journal:  Arch Neurol       Date:  2001-03

8.  Classification criteria for mild cognitive impairment: a population-based validation study.

Authors:  K Ritchie; S Artero; J Touchon
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

9.  Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R C Petersen; J C Stevens; M Ganguli; E G Tangalos; J L Cummings; S T DeKosky
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

10.  Screening for cognitive impairment in older individuals. Validation study of a computer-based test.

Authors:  R C Green; J Green; J M Harrison; M H Kutner
Journal:  Arch Neurol       Date:  1994-08
View more
  18 in total

1.  Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the "ON" medication state.

Authors:  Meir Plotnik; Nir Giladi; Yaacov Dagan; Jeffery M Hausdorff
Journal:  Exp Brain Res       Date:  2011-01-30       Impact factor: 1.972

2.  Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA.

Authors:  B Hanna-Pladdy; A Enslein; M Fray; B J Gajewski; R Pahwa; K E Lyons
Journal:  Int J Neurosci       Date:  2010-08       Impact factor: 2.292

3.  Neurocognitive testing in late-onset Tay-Sachs disease: a pilot study.

Authors:  D Elstein; G M Doniger; E Simon; I Korn-Lubetzki; R Navon; A Zimran
Journal:  J Inherit Metab Dis       Date:  2008-05-30       Impact factor: 4.982

4.  Validation of a self-administered computerized system to detect cognitive impairment in older adults.

Authors:  Samuel D Brinkman; Robert J Reese; Larry A Norsworthy; Donna K Dellaria; Jacob W Kinkade; Jared Benge; Kimberly Brown; Anna Ratka; James W Simpkins
Journal:  J Appl Gerontol       Date:  2012-09-18

5.  Computerized neuropsychological assessment devices: joint position paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology.

Authors:  Russell M Bauer; Grant L Iverson; Alison N Cernich; Laurence M Binder; Ronald M Ruff; Richard I Naugle
Journal:  Arch Clin Neuropsychol       Date:  2012-03-01       Impact factor: 2.813

6.  Computerized neuropsychological assessment devices: joint position paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology.

Authors:  Russell M Bauer; Grant L Iverson; Alison N Cernich; Laurence M Binder; Ronald M Ruff; Richard I Naugle
Journal:  Clin Neuropsychol       Date:  2012-03-07       Impact factor: 3.535

7.  The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the Reach for Health study.

Authors:  Sheri J Hartman; Sandahl H Nelson; Catherine R Marinac; Loki Natarajan; Barbara A Parker; Ruth E Patterson
Journal:  Psychooncology       Date:  2019-06-27       Impact factor: 3.894

8.  Cognitive function and other non-motor features in non-demented Parkinson's disease motor subtypes.

Authors:  Talia Herman; Aner Weiss; Marina Brozgol; Adi Wilf-Yarkoni; Nir Giladi; Jeffrey M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2014-12-10       Impact factor: 3.575

Review 9.  Applications of technology in neuropsychological assessment.

Authors:  Carolyn M Parsey; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2013-09-16       Impact factor: 3.535

Review 10.  Status of computerized cognitive testing in aging: a systematic review.

Authors:  Katherine Wild; Diane Howieson; Frank Webbe; Adriana Seelye; Jeffrey Kaye
Journal:  Alzheimers Dement       Date:  2008-11       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.